journal article·2025-09Open access

Therapeutic silicate biomaterials for sarcopenia treatment by inhibiting inflammation and enhancing muscle regeneration through regulation of Sarcolipin/SIRT signaling pathway

Zhen Zeng, Zhaowenbin Zhang, Lan Chang, Hanjiao Chen, Long Ren, Zhiqiang Huang, Yiren Jiao, Hangbin Xia, Chen Yang, Kui Luo, Jiang Chang

Abstract

Based on the observation of silicon content decrease in the muscles and serum with aging, this study proposes a silicate bioactive material based therapy for treating sarcopenia. Two therapeutic strategies were designed. One utilizes calcium silicate (CS) hydrogel for localized intramuscular treatment, and the other employs CS solution for systemic treatment through Intravenous injection. Both treatments restore silicon levels in the muscles and serum of aging mice, and show therapeutic effects on sarcopenia. Specifically, the CS hydrogel demonstrates more pronounced short-term efficacy in promoting local muscle regeneration, while the CS solution exhibits superior outcomes in modulating the overall condition of aging mice. The fundamental mechanism of the CS treatments on sarcopenia may involve the direct regulation of the SIRTs signaling pathway by silicate ions released from CS, as well as the indirect regulation of SIRTs pathway via the suppression of Sarcolipin (SLN) overexpression by silicate ions. Specifically, silicate ions directly upregulate SIRT1 expression in macrophages and on one side promote NF-kB deacetylation to inhibit M1 polarization, and on the other side facilitate STAT3 deacetylation to inhibit M2 polarization, ultimately reducing the expression of inflammatory factors (TNF-α, IL-6) and fibrotic factors (IL-10, TGF-β). Meanwhile, silicate ions directly upregulate SIRT3 in myoblasts, leading to the promotion of STAT3 dephosphorylation, inhibits mitochondrial reactive oxygen species (ROS) secretion, and enhances the expression of MyoD, MyoG, and Myosin, and accelerates myogenic differentiation. This bioactive CS based therapy provides a new approach for combating sarcopenia.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nutrition and Health in Aging · Muscle Physiology and Disorders · Autophagy in Disease and Therapy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (84)

Show source-provided references
2. Sarcopenia: revised European consensus on definition and diagnosis10.1093/ageing/afz046 ↗
3. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management10.1007/s12603-018-1139-9 ↗
4. Chapter 4 treatment of sarcopenia10.1111/ggi.13322 ↗
5. Protein and exercise in the prevention of sarcopenia and aging10.1016/j.nutres.2017.01.001 ↗
6. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids10.1016/S0002-8223(02)90346-9 ↗
7. Toward the recognition and management of sarcopenia in routine clinical care10.1038/s43587-021-00136-1 ↗
8. Immune clearance of senescent cells to combat ageing and chronic diseases10.3390/cells9030671 ↗
9. Konikowska · 2018 · 339
10. Relevance, essentiality and toxicity of trace elements in human health10.1016/j.mam.2005.07.013 ↗
11. Trace elements and cardiovascular diseases
12. Metalloenzymes and myocardial infarction: malic and lactic dehydrogenase activities and zinc concentrations in serum10.1056/NEJM195609062551001 ↗
13. Levels of selenium, zinc, copper, and cardiac troponin I in serum of patients with acute coronary syndrome10.1007/s12011-013-9754-0 ↗
14. The relationship between trace elements and cardiac markers in acute coronary syndromes10.1016/j.jtemb.2004.12.002 ↗
15. Serum trace elements are associated with hemostasis, lipid spectrum and inflammatory markers in men suffering from acute ischemic stroke10.1007/s11011-017-9967-6 ↗
16. Zn2SiO4 bioceramic attenuates cardiac remodeling after myocardial infarction
17. Copper promotes cardiac functional recovery via suppressing the transformation of fibroblasts to myofibroblasts in ischemia-infarcted monkey hearts10.1016/j.jnutbio.2022.109180 ↗
18. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies10.1038/s41419-023-05639-w ↗
19. Intracellular zinc release-activated ERK-dependent GSK-3β–p53 and Noxa–Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury10.1038/cdd.2011.80 ↗
20. The decrease in silicon concentration of the connective tissues with age in rats is a marker of connective tissue turnover10.1016/j.bone.2015.02.004 ↗
21. Silicate ions as soluble form of bioactive ceramics alleviate aortic aneurysm and dissection
22. Calcium silicate enhances immunosuppressive function of MSCs to indirectly modulate the polarization of macrophages10.1093/rb/rbab056 ↗
23. Ion therapy: a novel strategy for acute myocardial infarction
24. Silicate bioceramics enhanced vascularization and osteogenesis through stimulating interactions between endothelia cells and bone marrow stromal cells10.1016/j.biomaterials.2014.01.039 ↗
25. Bioglass promotes wound healing through modulating the paracrine effects between macrophages and repairing cells10.1039/C7TB01211J ↗
26. Synergistic effect of electrophysiological microenvironment and bioactive ions for enhancing bone regeneration10.1016/j.nanoen.2024.110113 ↗
27. Three‐dimensional bioprinting biphasic multicellular living scaffold facilitates osteochondral defect regeneration10.1002/idm2.12181 ↗
28. Magnesium-containing bioceramics stimulate exosomal miR-196a-5p secretion to promote senescent osteogenesis through targeting Hoxa7/MAPK signaling axis
29. Myeloid cell-specific mutation of Spi1 selectively reduces M2-biased macrophage numbers in skeletal muscle, reduces age-related muscle fibrosis and prevents sarcopenia10.1111/acel.13690 ↗
30. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages10.1038/s42255-020-00305-3 ↗
31. Geriatric muscle stem cells switch reversible quiescence into senescence10.1038/nature13013 ↗
32. Skewed macrophage polarization in aging skeletal muscle10.1111/acel.13032 ↗
33. The hallmarks of aging10.1016/j.cell.2013.05.039 ↗
34. Impact of aging on transition of acute kidney injury to chronic kidney disease
35. Targeting macrophages rescues age‐related immune deficiencies in C57 BL/6J geriatric mice10.1111/acel.12062 ↗
36. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation10.1016/j.cmet.2010.11.015 ↗
37. SIRT1 longevity factor suppresses NF‐κB‐driven immune responses: regulation of aging via NF‐κB acetylation?10.1002/bies.20799 ↗
38. STAT3 inhibition of gluconeogenesis is downregulated by SirT110.1038/ncb1857 ↗
39. SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway10.2147/OTT.S195234 ↗
40. Retracted: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma10.1002/jcb.27259 ↗
41. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression10.1007/s00262-017-2052-5 ↗
42. The world report on ageing and health: a policy framework for healthy ageing10.1016/S0140-6736(15)00516-4 ↗
43. Toward the recognition and management of sarcopenia in routine clinical care10.1038/s43587-021-00136-1 ↗
44. Sarcopenia–the search for emerging biomarkers10.1016/j.arr.2015.05.001 ↗
45. Searching for the link between inflammaging and sarcopenia10.1016/j.arr.2022.101611 ↗
46. Advance in drug delivery for ageing skeletal muscle
47. Advanced age impairs macrophage polarization10.1089/jir.2011.0058 ↗
48. The impact of ageing on monocytes and macrophages10.1016/j.imlet.2020.12.003 ↗
49. Molybdenum disulfide nanoflowers mediated anti-inflammation macrophage modulation for spinal cord injury treatment10.1016/j.jcis.2019.04.047 ↗
50. M1/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis10.1016/j.jconrel.2022.12.041 ↗
51. Dual functional monocytes modulate bactericidal and anti‐inflammation process for severe osteomyelitis treatment10.1002/smll.201905185 ↗
52. Macrophages promote renal fibrosis through direct and indirect mechanisms10.1038/kisup.2014.7 ↗
53. Roles of macrophage polarization and macrophage-derived miRNAs in pulmonary fibrosis10.3389/fimmu.2021.678457 ↗
54. Macrophages during the fibrotic process: M2 as friend and foe10.3389/fimmu.2015.00602 ↗
55. Calcium silicate-human serum albumin composite hydrogel decreases random pattern skin flap necrosis by attenuating vascular endothelial cell apoptosis and inflammation10.1016/j.cej.2021.130285 ↗
56. Regulation of immune response by bioactive ions released from silicate bioceramics for bone regeneration10.1016/j.actbio.2017.08.044 ↗
57. A new method for treating chronic pancreatitis and preventing fibrosis using bioactive calcium silicate ion solution10.1039/D3TB01287E ↗
58. Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment10.2337/db11-1415 ↗
59. Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco (endo) plasmic Ca2+-ATPases10.1073/pnas.0407815101 ↗
60. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals10.1038/nm.2897 ↗
61. Mammalian sirtuins: biological insights and disease relevance10.1146/annurev.pathol.4.110807.092250 ↗
62. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis10.1073/pnas.0803790105 ↗
64. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet10.1016/j.cmet.2013.09.004 ↗
65. Sirtuin 6 builds a wall against inflammation, trumping diabetes10.2337/dbi17-0025 ↗
66. Sirt1-hypoxia-inducible factor-1α interaction is a key mediator of tubulointerstitial damage in the aged kidney10.1111/acel.12904 ↗
67. Oxidative stress and vascular inflammation in aging10.1016/j.freeradbiomed.2013.07.003 ↗
68. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American heart association10.1161/RES.0000000000000110 ↗
69. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production10.1073/pnas.1111308108 ↗
70. Aging alters acetylation status in skeletal and cardiac muscles10.1007/s11357-020-00171-7 ↗
71. Oxidative stress in human pathology and aging: molecular mechanisms and perspectives10.3390/cells11030552 ↗
72. Cellular death, reactive oxygen species (ROS) and diabetic complications10.1038/s41419-017-0135-z ↗
73. Ion cocktail therapy for myocardial infarction by synergistic regulation of both structural and electrical remodeling
74. A biomaterial-based therapy for lower limb ischemia using Sr/Si bioactive hydrogel that inhibits skeletal muscle necrosis and enhances angiogenesis
75. The versatility and universality of calcium signalling10.1038/35036035 ↗
76. Apoptosis in muscle atrophy: relevance to sarcopenia10.1016/j.exger.2005.04.003 ↗
77. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management10.1007/s12603-018-1139-9 ↗
78. Chapter 4 treatment of sarcopenia10.1111/ggi.13322 ↗
79. Zn2SiO4 bioceramic attenuates cardiac remodeling after myocardial infarction10.1002/adhm.202203365 ↗
80. Strontium zinc silicate simultaneously alleviates osteoporosis and sarcopenia in tail-suspended rats via Piezo1-mediated Ca2+ signaling
81. Nobiletin prevents D-galactose-induced C2C12 cell aging by improving mitochondrial function10.3390/ijms231911963 ↗
82. Weischenfeldt · 2008
83. Slow Twitch soleus muscle is not protected from sarcopenia in senescent rats10.1016/j.exger.2010.04.001 ↗
84. Muscle ultrasound and sarcopenia in older individuals: a clinical perspective10.1016/j.jamda.2016.11.013 ↗